Patents by Inventor Antonio C. Llevares

Antonio C. Llevares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190298561
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 15, 2019
    Publication date: October 3, 2019
    Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Eleanor McCarthy
  • Publication number: 20190269541
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Application
    Filed: May 16, 2019
    Publication date: September 5, 2019
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Publication number: 20190209009
    Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
    Type: Application
    Filed: March 19, 2019
    Publication date: July 11, 2019
    Inventors: Mark C. Brister, Nelson Quintana, Antonio C. Llevares, John Michael Dobbles, Richard C. Yang, Michael Robert Mensinger
  • Patent number: 10327936
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: June 25, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
  • Publication number: 20190167163
    Abstract: Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system 800 comprising two working electrodes and at least one reference/counter electrode is provided. The sensor system 800 comprises first and second elongated bodies E1, E2, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layer 810 that separates the conductive layer 820 from the elongated body, a membrane layer deposited on top of the elongated bodies E1, E2, and working electrodes 802?, 802? formed by removing portions of the conductive layer 820 and the insulating layer 810, thereby exposing electroactive surface of the elongated bodies E1, E2.
    Type: Application
    Filed: January 17, 2019
    Publication date: June 6, 2019
    Inventors: Peter C. Simpson, Robert J. Boock, Paul V. Neale, Sebastian Böhm, Matthew Wightlin, Jack Pryor, Jason Mitchell, Jeff Jackson, Kaushik Patel, Antonio C. Llevares
  • Patent number: 10278580
    Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: May 7, 2019
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Antonio C. Llevares, John Michael Dobbles, Richard C. Yang, Michael Robert Mensinger
  • Publication number: 20190000655
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Application
    Filed: August 24, 2018
    Publication date: January 3, 2019
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D.L. VandenBerg
  • Patent number: 10085865
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: October 2, 2018
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Publication number: 20180221633
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: April 4, 2018
    Publication date: August 9, 2018
    Inventors: Mark C. Brister, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Amy D.L. VandenBerg, Antonio C. Llevares, Daniel Proctor
  • Publication number: 20180185185
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20180110640
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 25, 2016
    Publication date: April 26, 2018
    Applicant: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Sheldon Nelson, Daniel J. Proctor, Andrew P. Rasdal, Keoni John Sundseth, Amy D.L. VandenBerg, Betty Wong
  • Publication number: 20180064569
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 8, 2018
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D.L. VandenBerg
  • Publication number: 20180008446
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: August 29, 2017
    Publication date: January 11, 2018
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20180000388
    Abstract: Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system 800 comprising two working electrodes and at least one reference/counter electrode is provided. The sensor system 800 comprises first and second elongated bodies E1, E2, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layer 810 that separates the conductive layer 820 from the elongated body, a membrane layer deposited on top of the elongated bodies E1, E2, and working electrodes 802?, 802? formed by removing portions of the conductive layer 820 and the insulating layer 810, thereby exposing electroactive surface of the elongated bodies E1, E2.
    Type: Application
    Filed: August 22, 2017
    Publication date: January 4, 2018
    Inventors: Peter C. Simpson, Robert J. Boock, Paul V. Neale, Sebastian Böhm, Matthew Wightlin, Jack Pryor, Jason Mitchell, Jeff Jackson, Kaushik Patel, Antonio C. Llevares
  • Publication number: 20170367863
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. More particularly, apparatuses and methods for enabling volume-occupying intragastric devices to pass through the digestive system are provided.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 28, 2017
    Inventors: Eleanor McCarthy, Mark C. Brister, Antonio C. Llevares, Betty Wong
  • Patent number: 9827128
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: November 28, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9763608
    Abstract: Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system 800 comprising two working electrodes and at least one reference/counter electrode is provided. The sensor system 800 comprises first and second elongated bodies E1, E2, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layer 810 that separates the conductive layer 820 from the elongated body, a membrane layer deposited on top of the elongated bodies E1, E2, and working electrodes 802?, 802? formed by removing portions of the conductive layer 820 and the insulating layer 810, thereby exposing electroactive surface of the elongated bodies E1, E2.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: September 19, 2017
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert Boock, Paul V. Neale, Sebastian Böhm, Matthew Wightlin, Jack Pryor, Jason Mitchell, Jeff Jackson, Kaushik Patel, Antonio C. Llevares
  • Publication number: 20170156909
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: November 4, 2016
    Publication date: June 8, 2017
    Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Eleanor McCarthy
  • Patent number: 9662239
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: May 30, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20170079821
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Application
    Filed: December 5, 2016
    Publication date: March 23, 2017
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg